Arbutus Biopharma Corporation (ABUS) declined -33.99% or -3.09 to $6.0. It is close to 3.77 million shares traded, which is 1241.95% compare to the average total volume 303774. The market cap of ABUS is $332.43 million. The year to date change is 32.8%. The 52 week price range is from $4.3 to $12.6. Price of ABUS have changed -3.19% during last week. It have changed -9.10% over last month, 3.30% over last 3 months, 76.50% over last 6 months and 28.94% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ABUS is 9.66. It is 61.00% above current price. The 200-day Moving Averages for ABUS is 7.06. It is 17.67% above current price. The 52-week High is 12.6. It is 110.00% from the current price. The 52-week Low is 4.3. It is -28.33% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of ABUS is 5.12 on 2018-09-14. Short % to float is 3.26%. There are some statistics of ABUS. It is has market cap $332.43 million. The share outstanding is 55.40 million. The average volume is 303774. The revenue is 6.89M. The gross profit is -8645000. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ABUS is -45.57%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ABUS is -25.16%.